Isolated stem cell therapy for the treatment of diseases of the human body (Photo: AdobeStock/AGPhotography)

ISSCR Annual Meeting 2024

Be there when the brightest minds in stem cell research gather in Hamburg!

The Event

Networkers at heart

We would like to shape Life Science’s future – out of Northern Germany

About us
Nach unten
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)

SurgMark: FDA 510(k) Clearance for SchurSign Tissue Marker

In January SurgMark GmbH announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for ...

Read more …
The Stentrode™ Endovascular Electrode Array (Photo: Synchron)
The Stentrode™ Endovascular Electrode Array (Photo: Synchron)

Synchron Acquires Equity Stake in ACQUANDAS

Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the acquisition of an equity stake ...

Read more …
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)

"Stealth Effect"

An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...

Read more …

Evotec announces CEO transition

Evotec SE announced that after close to 15 years of successful service, CEO Dr Werner Lanthaler has informed the company, that he will not continue ...

Read more …

European XFEL: New Chairman of the Management Board

Physicist Prof Thomas Feurer has assumed the role of the new Chairman of the European XFEL Management Board on 1 January. Hailing from the University ...

Read more …

Cooperation for faster drug discovery

The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...

Read more …